CStone’s RET Inhibitor Gavreto Approved in Taiwan for Lung and Thyroid Cancers
CStone Pharmaceuticals (HKG: 2616) has announced receiving marketing approval in Taiwan for its RET inhibitor...
Ascletis Partners with Simcere for Ritonavir Supply in COVID-19 Drug Development
China-based Ascletis Pharma Inc. (HKG: 1672) has announced that its wholly-owned subsidiary Ascletis Pharmaceuticals Co.,...
Simcere’s COVID-19 Drug SIM0417 Accepted for Special Review by NMPA
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced that the National Medical Products Administration (NMPA)...
Bristol-Myers Squibb’s Opdivo Secures Two New Approvals for Esophageal Cancer in China
US-based pharmaceutical giant Bristol-Myers Squibb (BMS, NYSE: BMY) has received two new indication approvals in...
Henlius’ PD-1 Inhibitor HanSiZhuang Approved for First-Line SCLC Indication
Shanghai Henlius Pharmaceutical Co., Ltd (HKG: 2696) has announced receiving another indication approval from China’s...
Agilis Robotics Completes Successful Animal Testing for Surgical Robot
Hong Kong-based Agilis Robotics Ltd has successfully completed a second round of live animal testing...
CARsgen and Huadong Medicine Partner to Commercialize BCMA CAR-T Product CT053 in China
China-based CARsgen Therapeutics Holdings Limited (HKG: 2171), a leading developer of innovative CAR T-cell therapies,...
Tongshu Gene Partners with LC Gene to Distribute Gene Mutation Detection Kit in China
China-based gene testing service providers Tongshu Gene and LC Gene Diagnostics (Hangzhou) Co., Ltd. have...
3D Medicines’ 3D185 Receives Orphan Drug Designation for Gastric Cancer
China-based oncology specialist 3D Medicines (HKG: 1244) has announced receiving orphan drug designation (ODD) status...
Ascletis Pharma Initiates Dosing in Phase I Trial for COVID-19 Treatment ASC11
China-based Ascletis Pharma Inc. (HKG: 1672) has announced the dosing of four healthy subjects in...
Base Therapeutics Secures Series A1 Funding to Advance Gene Editing Pipelines
Base Therapeutics, a Guangdong-based firm specializing in base editing and prime editing technologies, has reportedly...
ConceMed Raises Pre-Series A Funding to Expand Digestive Endoscope Pipeline
ConceMed, a Guangdong-based maker of digestive soft electronic endoscopes, has reportedly raised “tens of millions”...
Luye Pharma’s Rykindo Receives FDA Approval for Schizophrenia and Bipolar I Disorder
China-based Luye Pharma Group (HKG: 2186) has announced receiving market approval from the US Food...
WuXi Biologics CEO Outlines Growth Amid Global Challenges at J.P. Morgan Conference
China-based WuXi Biologics (HKG: 2269) delivered a speech at the J.P. Morgan Healthcare Conference, where...
Hengrui’s Generic Cyclophosphamide Capsules Approved by China’s NMPA
China-based Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced receiving marketing approval from the National Medical...
ReLive Biotechnologies Acquires Co.Don AG, Secures USD 36 Million for Expansion
Tissue engineering and regenerative medicine start-up ReLive Biotechnologies Ltd has announced the full acquisition of...
Akeso’s Penpulimab Secures New Approval for Lung Cancer Indication
China-based Akeso Biopharma (HKG: 9926) has announced receiving another indication approval from the National Medical...
Clover Biopharmaceuticals Plans COVID-19 Vaccine SCB-2019 Launch in China for 2023
China-based Clover Biopharmaceuticals, Ltd (HKG: 2197) has provided updates on its plans for the commercialization...
Amoytop’s AK0706 Receives Clinical Trial Approval for Hepatitis B Treatment
Xiamen-based Amoytop Biotech Co. Ltd has announced receiving clinical trial approval from China’s National Medical...
JHM Biopharma Raises RMB100 Million to Expand Protein Drug Pipeline
Hangzhou-based protein drug developer JHM Biopharma has reportedly secured close to RMB100 million (USD14.9 million)...